TRIP12 and breast carcinoma: Finally, the TRIP12/FBW7/MCL-1 axis is well preserved in ovarian cancer but not in breast cancer cells since siRNA-mediated depletion of TRIP12 sensitized those cells to Taxol in an FBW7-dependent manner.